A detailed history of California State Teachers Retirement System transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 64,292 shares of CRNX stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,292
Previous 57,871 11.1%
Holding current value
$2.88 Million
Previous $2.06 Million 46.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$34.76 - $46.81 $223,193 - $300,567
6,421 Added 11.1%
64,292 $3.01 Million
Q4 2023

Feb 13, 2024

SELL
$25.62 - $37.07 $81,010 - $117,215
-3,162 Reduced 5.18%
57,871 $2.06 Million
Q3 2023

Nov 14, 2023

BUY
$15.97 - $30.59 $161,249 - $308,867
10,097 Added 19.82%
61,033 $1.82 Million
Q2 2023

Aug 21, 2023

SELL
$15.73 - $23.6 $27,055 - $40,592
-1,720 Reduced 3.27%
50,936 $917,000
Q1 2023

May 09, 2023

SELL
$15.31 - $21.1 $15,646 - $21,564
-1,022 Reduced 1.9%
52,656 $845,000
Q4 2022

Feb 14, 2023

BUY
$15.49 - $19.05 $10,347 - $12,725
668 Added 1.26%
53,678 $982,000
Q3 2022

Nov 18, 2022

SELL
$18.11 - $22.37 $24,050 - $29,707
-1,328 Reduced 2.44%
53,010 $1.04 Million
Q2 2022

Aug 15, 2022

BUY
$16.49 - $27.64 $98,296 - $164,762
5,961 Added 12.32%
54,338 $1.01 Million
Q1 2022

May 16, 2022

SELL
$17.15 - $28.31 $68,857 - $113,664
-4,015 Reduced 7.66%
48,377 $1.06 Million
Q4 2021

Feb 15, 2022

BUY
$19.35 - $28.41 $265,907 - $390,410
13,742 Added 35.55%
52,392 $1.49 Million
Q3 2021

Nov 15, 2021

SELL
$16.88 - $25.23 $197,563 - $295,291
-11,704 Reduced 23.24%
38,650 $814,000
Q2 2021

Aug 16, 2021

BUY
$15.9 - $21.15 $151,940 - $202,109
9,556 Added 23.42%
50,354 $949,000
Q2 2020

Aug 17, 2020

BUY
$13.04 - $23.23 $307,757 - $548,251
23,601 Added 137.24%
40,798 $715,000
Q1 2020

May 13, 2020

BUY
$11.52 - $26.46 $2,269 - $5,212
197 Added 1.16%
17,197 $253,000
Q2 2019

Aug 14, 2019

BUY
$21.48 - $27.71 $79,282 - $102,277
3,691 Added 27.73%
17,000 $425,000
Q1 2019

May 09, 2019

BUY
$21.07 - $29.31 $50,083 - $69,669
2,377 Added 21.74%
13,309 $303,000
Q4 2018

Feb 13, 2019

BUY
$22.4 - $35.39 $9,094 - $14,368
406 Added 3.86%
10,932 $328,000
Q3 2018

Nov 14, 2018

BUY
$22.66 - $36.8 $238,519 - $387,356
10,526 New
10,526 $302,000

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.41B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.